ArticleCurrent oncology (Toronto, Ont.)2022
Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study.
Roberta Maltoni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.